NSC |
Compound |
Enrichment |
Correlation |
NSC 685844 |
Null |
0.0252510646170347 |
-0.10724647 |
NSC 689547 |
Null |
0.0252510646170347 |
-0.016894274 |
NSC 639511 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.0252562667234373 |
0.08492902 |
NSC 656238 |
2-Methyl-4,8-dihydrobenzo[1,2-b:5,4-b']dithiophene-4,8-dione |
0.0252562667234373 |
0.35695611 |
NSC 736607 |
Null |
0.0252562667234373 |
0.08919226 |
NSC 107043 |
Null |
0.0268790882218881 |
0.26414248 |
NSC 120925 |
Null |
0.0268790882218881 |
0.48092814 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0268790882218881 |
0.40786931 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0268790882218881 |
-0.16716526 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.0268790882218881 |
0.14765979 |